A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

BACKGROUND: Iron deficiency anaemia is common in patients with chronic kidney disease, and intravenous iron is the preferred treatment for those on haemodialysis. The aim of this trial was to compare the efficacy and safety of iron isomaltoside 1000 (Monofer®) with iron sucrose (Venofer®) in haemodi...

Full description

Saved in:
Bibliographic Details
Published in:Nephrol Dial Transplant
Main Authors: Bhandari, Sunil, Kalra, Philip A., Kothari, Jatin, Ambühl, Patrice M., Christensen, Jeppe H., Essaian, Ashot M., Thomsen, Lars L., Macdougall, Iain C., Coyne, Daniel W.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2015
Subjects:
Clinical Science
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://ncbi.nlm.nih.gov/pubmed/25925701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv096
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items